BLOG

Looking for new mechanisms to cure hepatitis B

A genome editing tie-up between Gilead and Precision Biosciences, and promising early data with Arrowhead’s RNA interference project, are two novel approaches in hep B.

Back to the Blog .st0{stroke:#000;stroke-width:3}.st0,.st1{fill:none}